Kodiak Sciences Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
KOD$107.10+7.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Accrued and Other Current Liabilities
- Accrued and Other Current Liabilities
Accrued and other current liabilities consist of the following (in thousands):
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Accrued salaries and benefits | $7,770 | $5,266 |
| Accrued manufacturing and research & development costs | 6,238 | 2,148 |
| Accrued clinical trial and related costs | 4,494 | 2,803 |
| Accrued legal fees and professional fees | 824 | 443 |
| Accrued other liabilities | 1,281 | 370 |
| Total accrued and other current liabilities | $20,607 | $11,030 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.